Although Super Bowl LX’s ad lineup had plenty of the usual beer, car and tech company pitches, drug and other healthcare companies also shelled out $8 million for a 30-second spot to send their ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

Goetz is the creator of “Drug Story,” a new podcast about the disease business. Biologically, how the GLP-1 is delivered into the body should make little difference: It’s the same peptide, just in a ...

Thousands of patients are suing over alleged GLP-1 drug injuries. Drugs include Ozempic, Wegovy and Mounjaro.

Boxes for the GLP-1 medications Wegovy and Zepbound on May 8. (JoNel Aleccia/AP) You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click ...

Eli Lilly's GLP-1 drug is now the world's best-selling drug. Novo Nordisk is struggling with declining market share. Pfizer is desperately trying to get into the GLP-1 game. Three large pharmaceutical ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...